ITREL(R) TOTALLY IMPLANTABLE SPINAL CORD STIM. SYS
Medtronic Neuromodulation · Decision date Nov 30, 1984
What did the FDA approve?
FDA records P840001 as an original PMA application. The recorded decision is approval, dated Nov 30, 1984.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Nov 30, 1984
Regulatory record facts
- Identifier
- P840001
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic Neuromodulation
- Product code
- LGW
- Decision code
- APPR
- Decision date
- Nov 30, 1984
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.
- Applicant
- Medtronic Neuromodulation
- Product code
- LGW
- FDA device class
- 3
FDA decision timeline
P840001 received
Application receipt date recorded by FDA.
P840001 · FDA decision
APPR
P840001/S634 · Related supplement
Vantawith AdaptiveStim Technology - Model 977006
P840001/S632 · Related supplement
Master Vanta with Restore, Itrel, Synergy, Intellis, AdaptiveStim Vanta and Inceptiv TM Spinal Cord Implantable S
P840001/S635 · Related supplement
Master Restore, Itrel, Synergy Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify,
P840001/S636 · Related supplement
Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces-Quad, Specify,
Timeline entries are records held by MedtechLedger for P840001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P840001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Vantawith AdaptiveStim Technology - Model 977006P840001/S634 | Medtronic Neuromodulation | PMA supplement | Sep 24, 2026 | FDA |
| Medtronic Neuromodulation | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code LGW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Saluda Medical Evoke SCS SystemP190002/S052 | Saluda Medical Pty, Ltd. | PMA supplement | Oct 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P840001
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




